Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Circular & Notice of GM

23 Aug 2017 07:00

RNS Number : 7151O
Craven House Capital PLC
23 August 2017
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

Craven House Capital plc 

("Craven" or the "Company")

Publication of Circular & Notice of General Meeting

Transfer of Brazilian land holdings to DLC Holdings Corp. (the "DLC Transaction")

Convertible Debenture agreed with Global Emerging Markets Group

Repayment of Loan received

 

 

Craven House Capital plc (AIM: CRV) announces that it has agreed terms regarding the proposed transfer of its shareholdings in Ceniako Ltd ("Ceniako") and Craven House Industries Ltd ("CHI") to Toronto Stock Exchange listed DLC Holdings Corp (TSXV: DLC) in consideration for new ordinary shares in DLC Holdings Corp ("DLC"). DLC is an agricultural investment company, focused on owning and operating farmland and integrated agribusinesses. The proposed transaction is intended to unlock the value of the Company's Brazilian land holdings.

 

The Company intends to transfer its 49% shareholding in Ceniako, which owns, via a Brazilian subsidiary, a 1,973 hectare land parcel in Caravelas, situated in the state of Bahia, Brazil. Simultaneously, the 11.5% shareholder of Ceniako will also transfer its interest to DLC on the same terms, resulting in DLC having a 60.5% controlling interest in Ceniako. The Company also intends to transfer its 95% shareholding in CHI, which owns, via a Brazilian subsidiary, a 500 hectare land parcel in Canavieiras, also situated in the state of Bahia, Brazil.

 

These shareholdings will be transferred for a combined value of $9,034,000 and are currently held on the balance sheet of Craven at a value of $5,058,000. In consideration for the transfer, the Company will receive 57,461,906 shares in DLC, representing a 68% shareholding in DLC post-transaction. DLC and Craven share common directors and shareholders. Upon completion, DLC will become a majority-owned, publicly traded subsidiary of Craven House Capital plc.

 

Under the AIM Rules for Companies, the DLC Transaction is deemed a related party transaction. Consequently, the Independent Directors of the Company, having consulted with SPARK Advisory Partners Limited ("SPARK"), as Nominated Adviser to the Company, consider this transfer to be fair and reasonable in so far as shareholders are concerned. In providing advice to the Directors, SPARK has taken into account the Directors' commercial assessment of this related party transaction.

 

The Board believes that the proposed DLC Transaction will provide a number of benefits to existing shareholders of Craven, which are detailed further in a circular to shareholders (the "Circular"), which is being issued today.

 

These benefits include:

 

· A majority shareholding of DLC, which will in turn have majority shareholding in Ceniako.

· A "pure play" agricultural investment vehicle, which will provide investors access to a distinct asset class.

· Control of a publicly listed company with securities, which can be used as an acquisition currency for future acquisitions.

 

The Transaction constitutes a reverse takeover for DLC under the policies of the Toronto Stock Exchange ("TSX"). Requisite shareholder and regulatory approvals for the DLC Transaction will therefore also be required in Canada before completion. These include the approval of the DLC transaction by over 50% of the non-related shareholders of DLC Holdings. DLC Holdings has already received irrevocable undertakings from the required number of non-related shareholders required for the transaction to proceed.

 

The Transaction will also require approval by the TSX. The Board of DLC Holdings is in the process of gaining this approval and sees no reason why it will not be forthcoming. Approval of the TSX is anticipated to be received in approximately four to six weeks from the date of the Circular. In the event that this approval is not granted by the TSX then the DLC Transaction will not proceed.

 

The Company also announces that it intends to appoint Grant Thornton as its new auditors.

 

The Circular issued today contains a notice of a General Meeting to be convened on the 7th September 2017. The resolutions to be put to shareholders at the GM will propose the approval of the DLC Transaction and the appointment of Grant Thornton.

 

A copy of the Circular can be found on the Company's website: www.cravenhousecapital.com

 

 

Convertible Debenture with Global Emerging Markets Group

 

The Company also announces that it has entered into a zero coupon convertible debenture with GEM Global Yield Fund, a member of the New York based Global Emerging Markets Group ("GEM"). The $800,000 debenture has a term of five years and is convertible into a maximum of 200,000 shares of Craven. The debenture has been issued in lieu of fees due to GEM in relation to the £30m stock purchase agreement announced in November 2015.

 

Repayment of Loan

 

The Company also announces that it has received a partial repayment against the loan portfolio acquired by the Company in September 2016. A repayment of 21,663,537 South African Rand has been received. The Company continues work with borrowers to extract additional value from this portfolio of loans.

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

Tel: 0203 368 3550

 

 

 

About Craven House Capital:

 

Craven House Capital is a frontier and emerging market focused merchant bank seeking value oriented long term investments. Craven House invests in all segments of the capital structure in partnership with local entrepreneurs and the local business community. Craven House provides long term patient capital and is often involved in restructuring, expansion and turn around investments in crisis and transitioning economies.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGURGRUPMGRP
Date   Source Headline
2nd Mar 20104:45 pmPRNAnnual Financial Report
26th Feb 20102:38 pmRNSInterim Results
18th Feb 20107:00 amPRNRe Agreement Investment Advisory
8th Feb 20104:46 pmRNSDirectorate Change
29th Jan 20102:34 pmRNSTotal Voting Rights
13th Jan 20103:43 pmRNSHolding(s) in Company
29th Dec 200911:43 amRNSInvesting Policy
22nd Oct 20097:00 amRNSDirectorate Change
16th Oct 20092:30 pmRNSCapitalisation of Loan
6th Oct 20094:57 pmRNSHolding(s) in Company
5th Oct 20092:45 pmRNSDirectors' Shareholding
28th Sep 200911:26 amRNSDirector Resignation
14th Sep 20094:39 pmPRNHalf-yearly Report
11th Sep 20093:39 pmRNSDirectorate Change
11th Sep 20093:26 pmRNSAGM Statement
31st Jul 200911:51 amRNSNotice of AGM
31st Jul 20097:00 amRNSAnnual Report
2nd Jun 200910:30 amRNSHoldings in Company
29th May 20094:04 pmRNSDirector Shareholding
26th May 20091:15 pmRNSChange of Adviser
20th May 20094:50 pmRNSDirector/PDMR Shareholding
20th May 20094:47 pmRNSre: Sub-Division of Shares
20th May 20097:00 amRNSDirectorate Change
15th May 20092:31 pmRNSTrading Statement
13th May 20099:43 amPRNIncrease in Performance Fees
11th May 20097:00 amRNSRestoration - Medsea Estates Group plc
8th May 20095:15 pmRNSChange of Adviser
30th Apr 20092:37 pmRNSResult of EGM
27th Apr 200911:44 amRNSAddendum and Appt of Director
22nd Apr 200910:30 amRNSDirectorate Change
6th Apr 200912:10 pmRNSResignation of Nomad and Broker
6th Apr 200912:10 pmRNSSuspension - Medsea Estates Group plc
19th Mar 20093:48 pmRNSTrading Update- Replacement
19th Mar 200911:45 amRNSTrading Update
1st Dec 200810:20 amRNSDirectorate Change
10th Nov 200810:45 amRNSUpdate re proposed delisting
30th Sep 20084:17 pmRNSTotal Voting Rights
30th Sep 20087:00 amRNSInterim Results
8th Sep 200811:00 amRNSProposed cancellation of AIM
4th Sep 200811:37 amRNSResult of AGM
1st Sep 20083:06 pmRNSDirectorate Change
13th Aug 20089:17 amRNSNotice of AGM
4th Jul 200810:47 amRNSDirector/PDMR Shareholding
30th Jun 20084:00 pmRNSAnnual Report and Accounts
30th Jun 20087:00 amRNSFinal Results
30th Apr 200811:03 amRNSUpdate re Report & Accounts
18th Feb 20083:00 pmRNSDirector/PDMR Shareholding
13th Feb 20083:04 pmRNSTrading Statement
23rd Nov 20077:01 amRNSDirectorate Change
28th Sep 20077:05 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.